MS
Michal Sarfaty
Credentials: ·
History
- 2015–2019
Medical School
Research
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
The Breast · 2021 · 123 citations
Clinical Cancer Research · 2023 · 60 citations
Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma
European Urology · 2018 · First of 7 authors · Corresponding · 58 citations
- AM
15 papers · 13 as a resident
- HG
6 papers
5 papers
- GI
4 papers
3 papers
- DB
3 papers
- HA
3 papers
- MP
3 papers · 3 as a fellow